Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- Check6 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a new build of the page. This is a deployment update and does not appear to alter the study details or how the page is used.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page now shows Revision: v3.6.3, indicating a new UI/version tag and replacing the previous Revision: v3.6.2. This update appears to be a behind-the-scenes platform change rather than a modification to study content.SummaryDifference0.1%

- Check35 days agoChange DetectedAdded the Results section with detailed primary and secondary outcomes, including the composite CV death or worsening heart failure and the hierarchical win-ratio endpoint. The entry also includes Results First Posted dates and links to related publications and the study protocol.SummaryDifference3%

- Check49 days agoChange DetectedRecruitment status is updated to no longer recruit participants, indicating enrollment has ended. New navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and the Intervention/Treatment label was reformatted with the Revision tag updated to v3.6.0.SummaryDifference0.5%

- Check57 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a new version of the study record. This update reflects metadata changes rather than substantive alterations to trial content.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release. This change reflects metadata rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.